Learning Objectives:

1. Discuss NGS vs RFLP
2. Discuss NGS to guide treatment 
3. Discuss Limitations of gDST

Faculty/Presenter:

Robert Warren, MD, Speaker, has no relevant financial relationships to disclose.

Faculty member does not plan to discuss investigational uses


Disclosure Policy:
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.